title: Blocking potassium channels: a new principle for treating restenosis?
authors.forename: Andrea
authors.initials: A
authors.lastname: Olschewski
mesh_terms: D000818:Animals; D001157:Arterial Occlusive Diseases / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D002317:Cardiovascular Agents / Q000627:therapeutic use*; D002465:Cell Movement / Q000187:drug effects; D049109:Cell Proliferation / Q000187:drug effects; D003251:Constriction, Pathologic; D006801:Humans; D006965:Hyperplasia; D051664:Kv1.3 Potassium Channel / Q000037:antagonists & inhibitors* / Q000378:metabolism; D051379:Mice; D009131:Muscle, Smooth, Vascular / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D032389:Myocytes, Smooth Muscle / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D026902:Potassium Channel Blockers / Q000627:therapeutic use*; D012008:Recurrence; D017539:Tunica Intima / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology
chemical_list: D002317:Cardiovascular Agents; D051664:Kv1.3 Potassium Channel; D026902:Potassium Channel Blockers